Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Researchers call for more flexible editorial conduct rather than abruptly adopting only the new MASLD nomenclature
Amedeo Lonardo, Fernando Bril, Stephen H. Caldwell, et al.
Journal of Hepatology (2024) Vol. 80, Iss. 5, pp. e192-e194
Open Access | Times Cited: 24

Showing 24 citing articles:

Global burden of metabolic diseases, 1990–2021
Huai Zhang, Xiaodong Zhou, Michael D. Shapiro, et al.
Metabolism (2024) Vol. 160, pp. 155999-155999
Closed Access | Times Cited: 56
Non-invasive Scores and Serum Biomarkers for Fatty Liver in the Era of Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD): A Comprehensive Review From NAFLD to MAFLD and MASLD
Farah Abdelhameed, Chris Kite, Lukasz Lagojda, et al.
Current Obesity Reports (2024) Vol. 13, Iss. 3, pp. 510-531
Open Access | Times Cited: 30
Global prevalence of nonalcoholic fatty liver disease: an updated meta-analysis on 78 million population over 38 countries
Ehsan Amini‐Salehi, Negin Letafatkar, Naeim Norouzi, et al.
Archives of Medical Research (2024) Vol. 55, Iss. 6, pp. 103043-103043
Closed Access | Times Cited: 22
Guideline for the Prevention and Treatment of Metabolic Dysfunction-associated Fatty Liver Disease (Version 2024)
Jian‐Gao Fan, Xiaoyuan Xu, Rui-Xu Yang, et al.
Journal of Clinical and Translational Hepatology (2024) Vol. 000, Iss. 000, pp. 000-000
Open Access | Times Cited: 12
A global survey on the use of the international classification of diseases codes for metabolic dysfunction-associated fatty liver disease
Huai Zhang, Giovanni Targher, Christopher D. Byrne, et al.
Hepatology International (2024) Vol. 18, Iss. 4, pp. 1178-1201
Closed Access | Times Cited: 11
Non-alcoholic fatty liver disease and coexisting depression, anxiety and/or stress in adults: a systematic review and meta-analysis
Sue Shea, Christos Lionis, Chris Kite, et al.
Frontiers in Endocrinology (2024) Vol. 15
Open Access | Times Cited: 10
Metabolic characteristics of patients with MetALD: Caveats of a new definition
Erin Petrie, Meagan Gray, Fernando Bril
Liver International (2024) Vol. 44, Iss. 11, pp. 2929-2938
Closed Access | Times Cited: 10
Metabolic dysfunction-associated steatotic liver disease: Recent turning points for its diagnosis and management
Stergios A. Pοlyzos, Christos S. Mantzoros
Metabolism (2024) Vol. 157, pp. 155936-155936
Closed Access | Times Cited: 9
Association of NAFLD/NASH, and MAFLD/MASLD with chronic kidney disease: an updated narrative review
Amedeo Lonardo
Metabolism and Target Organ Damage (2024) Vol. 4, Iss. 2
Open Access | Times Cited: 7
Democracy in Science
Paolo Angeli
Journal of Hepatology (2024) Vol. 80, Iss. 5, pp. 676-677
Open Access | Times Cited: 4
“Fatty” or “steatotic”: position statement from a linguistic perspective by the Chinese-speaking community
Lei Miao, Shu-Mian Ye, Ming‐Hua Zheng, et al.
Journal of Hepatology (2024)
Closed Access | Times Cited: 4
From NAFLD to MASLD: what does it mean?
Lampros Chrysavgis, Εvangelos Cholongitas
Expert Review of Gastroenterology & Hepatology (2024) Vol. 18, Iss. 6, pp. 217-221
Closed Access | Times Cited: 4
Association between sleep duration and risk of nonalcoholic fatty liver disease: A systematic review and meta-analysis
Kasra Pirahesh, Ali Zarrinnia, Leila Nikniaz, et al.
Preventive Medicine Reports (2025) Vol. 50, pp. 102968-102968
Open Access
Unraveling Metabolic Dysfunction-Associated Steatotic Liver Disease Through the Use of Omics Technologies
Maria V. Bourganou, Maria Chondrogianni, Ioannis Kyrou, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 4, pp. 1589-1589
Open Access
Gut Microbiota and Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): Emerging Pathogenic Mechanisms and Therapeutic Implications
Farah Abdelhameed, A.I. Mustafa, Chris Kite, et al.
Livers (2025) Vol. 5, Iss. 1, pp. 11-11
Open Access
Dual etiology vs. MetALD: how MAFLD and MASLD address liver diseases coexistence
Shadi Zerehpooshnesfchi, Amedeo Lonardo, Jian-Gao Fan, et al.
Metabolism and Target Organ Damage (2025) Vol. 5, Iss. 1
Open Access
Metabolic (dysfunction)-associated fatty liver disease metrics and contributions to liver research
Maito Suoh, Saeed Esmaili, Mohammed Eslam, et al.
Hepatology International (2024)
Open Access | Times Cited: 3
From NAFLD to MAFLD and MASLD: a tale of alcohol, stigma and metabolic dysfunction
Stefano Ciardullo, Gianluca Perseghin
Metabolism and Target Organ Damage (2024)
Open Access | Times Cited: 2
Depression and the risk of non-alcohol fatty liver disease: Results from a cross-sectional study and a Mendelian randomization analysis
Duoduo Lv, Ning Han, Man Yuan, et al.
Journal of Affective Disorders (2024) Vol. 366, pp. 300-307
Closed Access | Times Cited: 2
Effect of metabolic dysfunction on the risk of liver-related events in patients cured of hepatitis C virus
Wei‐Fan Hsu, Hsueh‐Chou Lai, Sheng‐Hung Chen, et al.
American Journal of Cancer Research (2024) Vol. 14, Iss. 4, pp. 1914-1925
Open Access | Times Cited: 1
The MASLD‐MAFLD debate: Another phase of eminence versus evidence
Yasser Fouad, Safaa Mohamed Abdelhalim, Ebada Said, et al.
Liver International (2024) Vol. 44, Iss. 7, pp. 1742-1743
Closed Access | Times Cited: 1
Could controversies in the arena of fatty liver disease be a potential gate for the democratization of science
Yasser Fouad, Mohamed Alboraie, Ahmed Gomaa, et al.
Metabolism and Target Organ Damage (2024) Vol. 4, Iss. 3
Open Access
Cytokeratin 18 in nonalcoholic fatty liver disease: value and application
Yuan Wu, Jing Zhou, Jun Zhang, et al.
Expert Review of Molecular Diagnostics (2024), pp. 1-14
Closed Access
Transitions in the nomenclatures for fatty liver disease
Maito Suoh, Saeed Esmaili, Mohammed Eslam, et al.
Journal of Hepatology (2024)
Closed Access
Page 1

Scroll to top